Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10323089 Anti-transferrin receptor antibodies with tailored affinity

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
December 19, 2017
Date of Patent
June 18, 2019
Patent Application Number
15847448
Patent Citations Received
‌
US Patent 12104156 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 11999955 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 12071485 Compositions and methods of treating facioscapulohumeral muscular dystrophy
0
‌
US Patent 11525137 Compositions and methods of treating Facioscapulohumeral muscular dystrophy
‌
US Patent 11555190 Compositions and methods of treating Facioscapulohumeral muscular dystrophy
‌
US Patent 11584793 Anti-transferrin receptor antibodies with tailored affinity
‌
US Patent 11028179 Anti-transferrin receptor antibodies and uses thereof
‌
US Patent 11603411 Bispecific anti-human CD20/human transferrin receptor antibodies and methods of use
‌
US Patent 11707532 Compositions and methods of treating muscle dystrophy
0
‌
US Patent 11787868 Bispecific anti-human A-beta/human transferrin receptor antibodies and methods of use
•••
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
10323089
Patent Primary Examiner
‌
John D. Ulm

Find more entities like US Patent 10323089 Anti-transferrin receptor antibodies with tailored affinity

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo